About IBI-Ag
IBI-Ag is a company based in Ness Ziona (Israel) founded in 2017. IBI-Ag has raised $6.1 million across 4 funding rounds from investors including Bayer, The Trendlines Group and Corteva Agriscience. IBI-Ag offers products and services including Single Domain Antibody Bioinsecticides and Customized Biological Solutions. IBI-Ag operates in a competitive market with competitors including Terramera, UPL, Vestaron, MoA Technology and Micropep, among others.
- Headquarter Ness Ziona, Israel
-
Sectors
Chemicals & MaterialsAgriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ibi-Ag Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.1 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Bayer
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IBI-Ag
IBI-Ag offers a comprehensive portfolio of products and services, including Single Domain Antibody Bioinsecticides and Customized Biological Solutions.
Insecticides using antibodies to target pests selectively without environmental harm.
Platform for developing and testing bio-insect control based on research data.
People of IBI-Ag
Unlock access to complete
Funding Insights of IBI-Ag
IBI-Ag has successfully raised a total of $6.1M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IBI-Ag
IBI-Ag has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Bayer, The Trendlines Group and Corteva Agriscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup incubator for healthcare and agricultural companies
|
Locked | Locked | Locked | |
|
Venture capital fund and accelerator focused on tech startups
|
Locked | Locked | Locked | |
|
Consensus Business Group is engaged in ground rent investments.
|
Locked | Locked | Locked |
Investor details for IBI-Ag
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IBI-Ag
Investment portfolio details for IBI-Ag
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IBI-Ag
Detailed financials for IBI-Ag
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ibi-Ag Comparisons
Peer comparison for IBI-Ag
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IBI-Ag
IBI-Ag operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Terramera, UPL, Vestaron, MoA Technology and Micropep, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Plant-based biopesticides are developed for agricultural applications by Terramera.
|
|
| Locked | Locked | Locked |
Sustainable agriculture technologies and solutions are provided to farmers globally.
|
|
| Locked | Locked | Locked |
Biological insecticides and pesticides are developed from spider peptides.
|
|
| Locked | Locked | Locked |
Plant-based biologicals for weed control in agriculture are developed.
|
|
| Locked | Locked | Locked |
Plant-based crop protection products are developed for targeted agricultural applications.
|
|
| Locked | Locked | Locked |
Developing a patent protected product platform as a new class of insecticides
|
Detailed competitors of IBI-Ag
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ibi-Ag
Complete news archive for IBI-Ag
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IBI-Ag
IBI-Ag was founded in 2017 and raised its 1st funding round 4 years after it was founded.
IBI-Ag is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Shir Baor is the current CEO of IBI-Ag.
IBI-Ag is a funded company, having raised a total of $6.1M across 4 funding rounds to date.
Founded in 2017 and located in Ness Ziona, Israel, bio-insecticides are produced by the company using single domain antibody technology derived from natural proteins. Operations focus on developing targeted solutions that minimize effects on humans, plants, and non-target species while addressing various insect pests to support crop yield improvements in the agricultural sector.
IBI-Ag's top competitors include Terramera, Vestaron and MoA Technology.
IBI-Ag offers Single Domain Antibody Bioinsecticides and Customized Biological Solutions.
IBI-Ag has 8 investors. Key investors include Bayer, The Trendlines Group, Corteva Agriscience, Iron Nation, and Consensus Business Group.